
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5512-5512
Open Access | Times Cited: 40
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5512-5512
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 8
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 8
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Analytical approach of elemental impurities in pharmaceutical products: A worldwide review
Augusto Cezar Magalhães Aleluia, Morgana de Souza Nascimento, Ana Maria Pinto dos Santos, et al.
Spectrochimica Acta Part B Atomic Spectroscopy (2023) Vol. 205, pp. 106689-106689
Closed Access | Times Cited: 20
Augusto Cezar Magalhães Aleluia, Morgana de Souza Nascimento, Ana Maria Pinto dos Santos, et al.
Spectrochimica Acta Part B Atomic Spectroscopy (2023) Vol. 205, pp. 106689-106689
Closed Access | Times Cited: 20
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Omissions, Ambiguities, and Underuse of Causal Assessment Tools: a Systematic Review of Case Reports on Patients Who Use Kratom
Jeffrey D. Feldman, Destiny Schriefer, Kirsten E. Smith, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 293-303
Closed Access | Times Cited: 11
Jeffrey D. Feldman, Destiny Schriefer, Kirsten E. Smith, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 293-303
Closed Access | Times Cited: 11
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Herbal and dietary supplement induced liver injury: Highlights from the recent literature
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 25
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 25
Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
Catherine W. Striley, Carolin C. Hoeflich, Andrew T Viegas, et al.
Substance Abuse Research and Treatment (2022) Vol. 16
Open Access | Times Cited: 16
Catherine W. Striley, Carolin C. Hoeflich, Andrew T Viegas, et al.
Substance Abuse Research and Treatment (2022) Vol. 16
Open Access | Times Cited: 16
Interpol Review of Drug Analysis 2019-2022
David J. Love, Nicole S. Jones
Forensic Science International Synergy (2023) Vol. 6, pp. 100299-100299
Open Access | Times Cited: 9
David J. Love, Nicole S. Jones
Forensic Science International Synergy (2023) Vol. 6, pp. 100299-100299
Open Access | Times Cited: 9
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Respiratory effects of oral mitragynine and oxycodone in a rodent model
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 5, pp. 429-439
Open Access | Times Cited: 13
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 5, pp. 429-439
Open Access | Times Cited: 13
Public Health Implications and Possible Sources of Lead (Pb) as a Contaminant of Poorly Regulated Kratom Products in the United States
Walter C. Prozialeck, Alexandra Fowler, Joshua R. Edwards
Toxics (2022) Vol. 10, Iss. 7, pp. 398-398
Open Access | Times Cited: 9
Walter C. Prozialeck, Alexandra Fowler, Joshua R. Edwards
Toxics (2022) Vol. 10, Iss. 7, pp. 398-398
Open Access | Times Cited: 9
Discovery, evaluation, prevention, and control of liver injury risk by Polygoni Multiflori Radix
Can Tu, Yuan Gao, Zhaofang Bai, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 2, pp. 271-281
Open Access | Times Cited: 1
Can Tu, Yuan Gao, Zhaofang Bai, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 2, pp. 271-281
Open Access | Times Cited: 1
Kratom as a potential substance use disorder harm reduction agent
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Liver injury in patients with substance use disorder
Kevin Robinson, Lynda M. Coraluzzi, Victor J. Navarro
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Kevin Robinson, Lynda M. Coraluzzi, Victor J. Navarro
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Dynamic Topic Modeling of Kratom Use and Experiences: Insights on 13 years of Reddit Discussions
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1
Analysis of heavy metals content in commercially available kratom products in Richmond, Virginia
James H. Fleming, Carol M. Babyak, Emanuele Amorim Alves
Forensic Chemistry (2023) Vol. 33, pp. 100474-100474
Closed Access | Times Cited: 4
James H. Fleming, Carol M. Babyak, Emanuele Amorim Alves
Forensic Chemistry (2023) Vol. 33, pp. 100474-100474
Closed Access | Times Cited: 4
Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1
Suspected Fanconi syndrome from cadmium toxicity exacerbated by heavy kratom use. A rare occurrence
Arjun Sekar, S. Velani, Samantha Katzman, et al.
Clinical Toxicology (2022) Vol. 60, Iss. 7, pp. 888-889
Closed Access | Times Cited: 7
Arjun Sekar, S. Velani, Samantha Katzman, et al.
Clinical Toxicology (2022) Vol. 60, Iss. 7, pp. 888-889
Closed Access | Times Cited: 7